SARS-CoV-2 vaccines: A double-edged sword throughout rapid evolution of COVID-19.
SARS-CoV-2
antibody-dependent enhancement
neutralizing antibodies
vaccine
Journal
Cell biology international
ISSN: 1095-8355
Titre abrégé: Cell Biol Int
Pays: England
ID NLM: 9307129
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
revised:
12
07
2022
received:
19
12
2021
accepted:
24
08
2022
pubmed:
2
9
2022
medline:
19
11
2022
entrez:
1
9
2022
Statut:
ppublish
Résumé
After more than 2 years of the coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2, several questions have remained unanswered that affected our daily lives. Although substantial vaccine development could resist this challenge, emerging new variants in different countries could be considered as potent concerns regarding the adverse effects of reinfection or postvaccination. Precisely, these concerns address some significant and probable outcomes in vaccinated or reinfected models, followed by some virus challenges, such as antibody-dependent enhancement and cytokine storm. Therefore, the importance of evaluating the effectiveness of neutralizing antibodies (nAbs) elicited by vaccination and the rise of new variants must be addressed.
Identifiants
pubmed: 36047303
doi: 10.1002/cbin.11903
pmc: PMC9539123
doi:
Substances chimiques
Antibodies, Viral
0
COVID-19 Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2009-2017Subventions
Organisme : Tabriz University of Medical Sciences
ID : 65697
Informations de copyright
© 2022 International Federation for Cell Biology.
Références
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Cell Res. 2020 Apr;30(4):343-355
pubmed: 32231345
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
J Virol. 2012 Dec;86(24):13202-16
pubmed: 23055555
Cell Mol Immunol. 2021 May;18(5):1305-1307
pubmed: 33742186
Biosci Rep. 2020 May 29;40(5):
pubmed: 32378705
Cell Mol Immunol. 2020 May;17(5):554
pubmed: 32024976
Int J Mol Sci. 2020 May 10;21(9):
pubmed: 32397684
Lancet. 2004 Jun 26;363(9427):2122-7
pubmed: 15220033
Hum Vaccin Immunother. 2021 Nov 2;17(11):4121-4125
pubmed: 34543154
Vaccine. 2007 Jan 8;25(4):729-40
pubmed: 17049691
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Cell Mol Immunol. 2020 Jun;17(6):621-630
pubmed: 32415260
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cell. 2021 Apr 1;184(7):1671-1692
pubmed: 33743212
Gene Rep. 2020 Jun;19:100682
pubmed: 32300673
Int J Health Serv. 2021 Oct;51(4):570-572
pubmed: 34106781
J Med Virol. 2022 May;94(5):1821-1824
pubmed: 34936120
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Ther Adv Vaccines Immunother. 2018 Oct 12;6(4):61-68
pubmed: 30345419
J Indian Inst Sci. 2022;102(2):671-687
pubmed: 35136306
mBio. 2021 Oct 26;12(5):e0198721
pubmed: 34579572
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
J Biol Chem. 2004 Jan 30;279(5):3197-201
pubmed: 14670965
Front Mol Biosci. 2020 Jul 03;7:157
pubmed: 32719810
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64
pubmed: 14651994
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
Viruses. 2010 Aug;2(8):1804-1820
pubmed: 21994708
J Virol. 1992 Nov;66(11):6695-705
pubmed: 1383568
J Virol. 1998 Aug;72(8):6838-50
pubmed: 9658133
J Gen Virol. 2002 Sep;83(Pt 9):2091-2108
pubmed: 12185262
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163
pubmed: 32265180
Cell Biol Int. 2022 Dec;46(12):2009-2017
pubmed: 36047303
Life Sci. 2020 Sep 1;256:117883
pubmed: 32497632
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Rev Med Virol. 2020 Nov;30(6):1-9
pubmed: 32734714
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801
pubmed: 15642942
J Virol. 1990 Mar;64(3):1407-9
pubmed: 2154621
Yonsei Med J. 2021 Nov;62(11):961-968
pubmed: 34672129
Front Immunol. 2021 Jul 08;12:660632
pubmed: 34305892
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
J Vasc Interv Radiol. 2018 Apr;29(4):441-453
pubmed: 29478797
J Immunol. 1995 Jun 1;154(11):6163-73
pubmed: 7751656
Int J Mol Sci. 2021 Oct 25;22(21):
pubmed: 34768911
Clin Microbiol Rev. 2020 Jun 24;33(4):
pubmed: 32580969
Front Microbiol. 2018 Dec 05;9:2991
pubmed: 30568643
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Front Immunol. 2020 Sep 11;11:552909
pubmed: 33013925
Vaccine. 2007 Apr 12;25(15):2832-8
pubmed: 17092615
Signal Transduct Target Ther. 2020 May 29;5(1):84
pubmed: 32467561
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8
pubmed: 17620608
Front Immunol. 2021 Aug 17;12:693775
pubmed: 34484190
Virusdisease. 2020 Jun;31(2):200-203
pubmed: 32377556
J Exp Med. 1977 Jul 1;146(1):201-17
pubmed: 406347
J Immunol. 1991 Nov 1;147(9):3139-44
pubmed: 1680925
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Nat Rev Immunol. 2020 Jun;20(6):347-348
pubmed: 32346094
Am J Epidemiol. 1981 Nov;114(5):632-48
pubmed: 6272572
Annu Rev Immunol. 2013;31:705-42
pubmed: 23330954
Nature. 2020 Jul;583(7818):669-670
pubmed: 32710003
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
J Exp Med. 1983 Jul 1;158(1):258-63
pubmed: 6864163
Virusdisease. 2020 Mar;31(1):13-21
pubmed: 32206694
Immunology. 2020 Jul;160(3):261-268
pubmed: 32460357
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6
pubmed: 15096611
ACS Infect Dis. 2016 May 13;2(5):361-76
pubmed: 27627203
Immunology. 2021 Jan;162(1):30-43
pubmed: 32935333
Cell Biosci. 2021 Jul 19;11(1):136
pubmed: 34281608
J Virol. 2021 Jun 10;95(13):e0021921
pubmed: 33853957
Nat Immunol. 2022 Feb;23(2):165-176
pubmed: 35105981
J Clin Med. 2020 May 14;9(5):
pubmed: 32422996
Nature. 2004 Apr 1;428(6982):561-4
pubmed: 15024391
Int J Infect Dis. 2021 Oct;111:164-168
pubmed: 34454118
Immunity. 2021 Feb 9;54(2):205-210
pubmed: 33513337
Immunity. 2021 Jan 12;54(1):14-18
pubmed: 33406391
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211024372
pubmed: 34211709
Cell Host Microbe. 2012 Oct 18;12(4):396-407
pubmed: 23084910
J Infect Dis. 1995 Sep;172(3):855-8
pubmed: 7658082
Annu Rev Immunol. 2003;21:515-46
pubmed: 12500980
Virology. 1967 Oct;33(2):250-61
pubmed: 6053142
Cells. 2020 Oct 22;9(11):
pubmed: 33105869
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Viruses. 2021 Dec 11;13(12):
pubmed: 34960752
NPJ Vaccines. 2021 Apr 13;6(1):53
pubmed: 33850138
J Virol. 2018 Jun 29;92(14):
pubmed: 29720522
J Immunol. 2008 Nov 1;181(9):6337-48
pubmed: 18941225
Rev Esp Quimioter. 2021 Oct;34(5):419-428
pubmed: 34076402
Biophysics (Oxf). 2020;65(4):703-709
pubmed: 33100352
Microbiol Mol Biol Rev. 2016 Oct 26;80(4):989-1010
pubmed: 27784796